benzocaine 20 MG/ML / cetylpyridinium chloride 1 MG/ML / menthol 5 MG/ML Mucosal Spray
RxNorm concept 1426687, clinical drug (scd). Prescribable name: benzocaine 2 % / cetylpyridinium chloride 0.1 % / menthol 0.5 % Mucosal Spray.
- RxCUI
- 1426687
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1426687 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
benzocaine 2 % / cetylpyridinium chloride 0.1 % / menthol 0.5 % Mucosal Spray
Related concepts
- benzocaine 20 MG/ML (SCDC, consists of)
- menthol 5 MG/ML (SCDC, consists of)
- cetylpyridinium chloride 1 MG/ML (SCDC, consists of)
- Mucosal Spray (DF, has dose form)
- benzocaine 20 MG/ML / cetylpyridinium chloride 1 MG/ML / menthol 5 MG/ML Mucosal Spray [Orasep Reformulated Dec 2013] (SBD, has tradename)
Linked data
NDCs
- 63102010701
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1426687 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1426687 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1426687. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.